Combined ultrasound and biochemistry for risk evaluation in the first trimester: The Stockholm experience of a new web-based system

Acta Obstetricia et Gynecologica Scandinavica

Volumn 91, Issue 1, 2012, Pages 34-38

  Conner, Peter ^a   Westgren, Magnus ^a   Marsk, Anna ^b   Gustafsson, Sven ^a   Kublickas, Marius ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

Author keywords

Combined risk assessment; Down's syndrome; first trimester; screening; web based system

Indexed keywords

ADOLESCENT; ADULT; ALGORITHM; ARTICLE; BIOCHEMISTRY; CHROMOSOME ABERRATION; DOWN SYNDROME; ECHOGRAPHY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INCIDENCE; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; PRIORITY JOURNAL; RISK ASSESSMENT; TRISOMY 13; TRISOMY 18; TRISOMY 21;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 18; DOWN SYNDROME; FEMALE; HUMANS; INCIDENCE; INTERNET; MIDDLE AGED; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SOFTWARE; SWEDEN; TRISOMY; YOUNG ADULT;

EID: 83455195353     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2011.01268.x     Document Type: Article

References (17)

1. Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH,. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol. 2008; 31: 618-24.
2. Stenhouse EJ, Crossley JA, Aitken DA, Brogan K, Cameron AD, Connor JM,. First-trimester combined ultrasound and biochemical screening for Down syndrome in routine clinical practice. Prenat Diagn. 2004; 24: 774-80. (Pubitemid 39468656)
3. Borrell A, Casals E, Fortuny A, Farre MT, Gonce A, Sanchez A, et al. First-trimester screening for trisomy 21 combining biochemistry and ultrasound at individually optimal gestational ages. An interventional study. Prenat Diagn. 2004; 24: 541-5. (Pubitemid 39061909)
4. Ekelund CK, Jorgensen FS, Petersen OB, Sundberg K, Tabor A,. Impact of a new national screening policy for Down's syndrome in Denmark: population based cohort study. Br Med J. 2008; 337: a2547.
5. Tabor A, Vestergaard CH, Lidegaard O,. Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study. Ultrasound Obstet Gynecol. 2009; 34: 19-24.
6. Kublickas M, Crossley J, Aitken D,. Screening for Down's syndrome in the first trimester: combined risk calculation, methodology, and validation of a web-based system. Acta Obstet Gynecol Scand. 2009; 88: 635-8, 7p following 8.
7. Snijders RJ, Sundberg K, Holzgreve W, Henry G, Nicolaides KH,. Maternal age- and gestation-specific risk for trisomy 21. Ultrasound Obstet Gynecol. 1999; 13: 167-70. (Pubitemid 29176889)
8. Spencer K, Bindra R, Cacho AM, Nicolaides KH,. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy. Prenat Diagn. 2004; 24: 169-73. (Pubitemid 38428854)
9. Wortelboer EJ, Koster MP, Stoutenbeek P, Elvers LH, Loeber JG, Visser GH, et al. First-trimester Down syndrome screening performance in the Dutch population; how to achieve further improvement? Prenat Diagn. 2009; 29: 588-92.
10. Wojdemann KR, Christiansen M, Sundberg K, Larsen SO, Shalmi A, Tabor A,. Quality assessment in prospective nuchal translucency screening for Down syndrome. Ultrasound Obstet Gynecol. 2001; 18: 641-4. (Pubitemid 34063067)
11. Wright D, Syngelaki A, Birdir C, Bedei I, Nicolaides KH,. First-trimester screening for Trisomy 21 with adjustment for biochemical results of previous pregnancies. Fetal Diagn Ther. 2011; Jun 25 [E-pub ahead of print].
12. Marttala J, Yliniemi O, Gissler M, Nieminen P, Ryynanen M,. Prevalence of Down's syndrome in a pregnant population in Finland. Acta Obstet Gynecol Scand. 2010; 89: 715-7.
13. Saltvedt S, Almstrom H, Kublickas M, Valentin L, Bottinga R, Bui TH, et al. Screening for Down syndrome based on maternal age or fetal nuchal translucency: a randomized controlled trial in 39,572 pregnancies. Ultrasound Obstet Gynecol. 2005; 25: 537-45. (Pubitemid 40835455)
14. Tabor A, Philip J, Madsen M, Bang J, Obel EB, Norgaard-Pedersen B,. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet. 1986; i: 1287-93.
15. Spencer K, Heath V, El-Sheikhah A, Ong CY, Nicolaides KH,. Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro-Caribbean populations. Prenat Diagn. 2005; 25: 365-9. (Pubitemid 40813777)
16. Wright D, Spencer K, Kagan KK, Torring N, Petersen OB, Christou A, et al. First-trimester combined screening for trisomy 21 at 7-14 weeks' gestation. Ultrasound Obstet Gynecol. 2010; 36: 404-11.
17. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM,. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess. 2003; 7: 1-77.